These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 20044628

  • 1. Docetaxel, ifosfamide and cisplatin (DIP) in squamous cell carcinoma of the head and neck.
    Specenier PM, Van Den Brande J, Schrijvers D, Huizing MT, Altintas S, Dyck J, Van Den Weyngaert D, Van Laer C, Vermorken JB.
    Anticancer Res; 2009 Dec; 29(12):5137-42. PubMed ID: 20044628
    [Abstract] [Full Text] [Related]

  • 2. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
    Rapidis AD, Trichas M, Stavrinidis E, Roupakia A, Ioannidou G, Kritselis G, Liossi P, Giannakouras G, Douzinas EE, Katsilieris I.
    Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029
    [Abstract] [Full Text] [Related]

  • 3. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.
    Shin DM, Glisson BS, Khuri FR, Lippman SM, Ginsberg L, Diaz E, Papadimitrakopoulou V, Feng L, Francisco M, Garden A, Kies MS, Myers J, Clayman G, Hong WK.
    Cancer; 2002 Jul 15; 95(2):322-30. PubMed ID: 12124833
    [Abstract] [Full Text] [Related]

  • 4. Dose-finding study of docetaxel added to ifosfamide and cisplatin followed by concomitant capecitabine and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Recchia F, Saggio G, Cesta A, Amiconi G, di Blasio A, Candeloro G, Valeriani M, Tombolini V, Rea S.
    Anticancer Res; 2006 Jul 15; 26(3B):2317-24. PubMed ID: 16821609
    [Abstract] [Full Text] [Related]

  • 5. Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM, Glisson BS, Khuri FR, Hong WK, Lippman SM.
    Semin Oncol; 1998 Apr 15; 25(2 Suppl 4):40-4; discussion 45-8. PubMed ID: 9578061
    [Abstract] [Full Text] [Related]

  • 6. Phase I trial of combined chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for patients with locally advanced squamous cell carcinoma of the head and neck.
    Tsukuda M, Mikami Y, Tanigaki Y, Katori H, Horiuchi C, Ikeda Y, Taguchi T, Ono M, Yoshida T, Sakuma Y, Aikoh K.
    Int J Clin Oncol; 2004 Jun 15; 9(3):161-6. PubMed ID: 15221599
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A phase II trial of docetaxel, cisplatin and 5-fluorouracil in patients with recurrent squamous cell carcinoma of the head and neck (SCCHN).
    Baghi M, Hambek M, Wagenblast J, May A, Gstoettner W, Knecht R.
    Anticancer Res; 2006 Jun 15; 26(1B):585-90. PubMed ID: 16739325
    [Abstract] [Full Text] [Related]

  • 16. Adjuvant docetaxel, cisplatin and 5-fluorouracil (TPF) in locally advanced squamous cell carcinoma of the head and neck.
    Baghi M, Hambek M, May A, Radeloff A, Gstoettner W, Knecht R.
    Anticancer Res; 2006 Jun 15; 26(1B):559-63. PubMed ID: 16739320
    [Abstract] [Full Text] [Related]

  • 17. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
    Papadimitrakopoulou VA, Dimery IW, Lee JJ, Perez C, Hong WK, Lippman SM.
    Cancer J Sci Am; 1997 Jun 15; 3(2):92-9. PubMed ID: 9099459
    [Abstract] [Full Text] [Related]

  • 18. Prospective pilot study of consolidation chemotherapy with docetaxel and cisplatin after concurrent chemoradiotherapy for advanced head and neck cancer.
    Lee KC, Lee SH, Lee Y, Park SH, Park J, Cho EK, Shin DB, Lee JH, Kim DY, Kim ST.
    Int J Radiat Oncol Biol Phys; 2008 May 01; 71(1):187-91. PubMed ID: 17996392
    [Abstract] [Full Text] [Related]

  • 19. A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
    Worden FP, Moon J, Samlowski W, Clark JI, Dakhil SR, Williamson S, Urba SG, Ensley J, Hussain MH, Southwest Oncology Group, Head and Neck Working Group.
    Cancer; 2006 Jul 15; 107(2):319-27. PubMed ID: 16779801
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of dose-modified docetaxel plus cisplatin-based induction chemotherapy in Asian patients with locally advanced head and neck cancer.
    Huang CE, Lu CH, Chen PT, Chan CH, Chen WC, Wang WH, Wu JY, Kuan FC, Lee KD, Chen CC.
    J Clin Pharm Ther; 2012 Jun 15; 37(3):342-7. PubMed ID: 21950487
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.